Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:03 PM
Ignite Modification Date:
2025-12-24 @ 12:03 PM
NCT ID:
NCT06524661
Eligibility Criteria:
Inclusion Criteria:
* • Patients with rhegmatogenous retinal detachment who are going to undergo vitreoretinal surgery with silicone oil 1000cs injection as tamponade
Exclusion Criteria:
* Patients with history of intraocular surgery, laser therapy or intravitreal injection.
* Patients with significant corneal opacity.
* Patients with ocular diseases as retinal vein occlusion, uveitis and proliferative diabetic retinopathy.
* Patients with preexisting glaucoma or family history of glaucoma.
* Patients with nystagmus.
* Patient with tractional retinal detachment, exudative retinal detachment or intraocular foreign body.
* Patients with anterior chamber abnormalities including posterior synechia, peripheral anterior synechia, hyphaema and iris abnormalities.
* Patients with severe proliferative vitreoretinopathy grade C or more.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Maximum Age:
75 Years
Study:
NCT06524661
Study Brief:
Protocol Section:
NCT06524661